Navegar

Colección

Datos Estadísticas

Lista de

epidermal growth factor receptor 2
16
"Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC" (2017) Guttlein, L.N.;Benedetti, L.G.;Fresno, C. (...)Podhajcer, O.L. Molecular Cancer Research. 15(3):304-316
"Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC" (2017) Guttlein, L.N.;Benedetti, L.G.;Fresno, C. (...)Podhajcer, O.L. Molecular Cancer Research. 15(3):304-316
"Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models" (2017) Toscani, A.M.;Sampayo, R.G.;Barabas, F.M. (...)Leskow, F.C. PLoS ONE. 12(3)
"Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models" (2017) Toscani, A.M.;Sampayo, R.G.;Barabas, F.M. (...)Leskow, F.C. PLoS ONE. 12(3)
"Driving CARs into Sweet Roads: Targeting Glycosylated Antigens in Cancer" (2016) Blidner, A.G.; Mariño, K.V.; Rabinovich, G.A. Immunity. 44(6):1248-1250
"Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer" (2012) Schillaci, R.;Guzmán, P.;Cayrol, F. (...)Elizalde, P.V. BMC Cancer. 12
"Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer" (2012) Schillaci, R.;Guzmán, P.;Cayrol, F. (...)Elizalde, P.V. BMC Cancer. 12
"Expression of erythroblastic leukemia viral oncogene homolog (erbBS) mRNAs and possible splice variants in 3T3-L1 preadipocytes" (2011) Pagano, E.; Fontana, V.; Calvo, J.C. Molecular Medicine Reports. 4(5):955-961
"Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth" (2009) Proietti, C.J.;Rosemblit, C.;Beguelin, W. (...)Elizalde, P.V. Molecular and Cellular Biology. 29(5):1249-1265
"Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth" (2009) Proietti, C.J.;Rosemblit, C.;Beguelin, W. (...)Elizalde, P.V. Molecular and Cellular Biology. 29(5):1249-1265
"Down-modulation of erbB2 activity is necessary but not enough in the differentiation of 3T3-L1 preadipocytes" (2008) Pagano, E.; Coso, O.; Calvo, J.C. Journal of Cellular Biochemistry. 104(1):274-285
"Down-modulation of erbB2 activity is necessary but not enough in the differentiation of 3T3-L1 preadipocytes" (2008) Pagano, E.; Coso, O.; Calvo, J.C. Journal of Cellular Biochemistry. 104(1):274-285
"Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction" (2004) Lidke, D.S.;Nagy, P.;Heintzmann, R. (...)Jovin, T.M. Nature Biotechnology. 22(2):198-203
"Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer " (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Medicina. 64(2):129-134